$AYTU
AYTU BioPharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.12
▲+5.95%+$0.119
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAYTU BioPharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is AYTU up today? It is at $2.12 (+5.95%). See the catalyst behind the move, real-time alerts the moment AYTU spikes, and full due diligence on AYTU — key stats, earnings, dilution and insider activity. Free.
Be first to know when $AYTU makes an unusual move. Create a free account to track $AYTU, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AYTU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AYTU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Donofrio John Jr. Director | Acquired (grant/award) | +10K 0.09% of company | added 73% | 24K | n/a | Jul 28, 26 |
Dockery Carl Director | Acquired (grant/award) | +10K 0.09% of company | added 47% | 31K | n/a | Jul 28, 26 |
Jain Abhinav Director | Acquired (grant/award) | +10K 0.09% of company | added 51% | 30K | n/a | Jul 28, 26 |
Liu Vivian H Director | Acquired (grant/award) | +10K 0.09% of company | added 50% | 30K | n/a | Jul 28, 26 |
Selhorn Ryan J Officer | Acquired (grant/award) | +25K 0.2% of company | added 50% | 75K | n/a | Jul 28, 26 |
Disbrow Jarrett Officer | Acquired (grant/award) | +15K 0.1% of company | added 24% | 77K | n/a | Jul 28, 26 |
Pyszczymuka Greg Officer | Acquired (grant/award) | +20K 0.2% of company | added 55% | 56K | n/a | Jul 28, 26 |
Disbrow Joshua R. Officer | Acquired (grant/award) | +30K 0.3% of company | added 14% | 237K | n/a | Jul 28, 26 |
Donofrio John Jr. Director | Acquired (grant/award) | +10K 0.09% of company | added 100% | 14K | n/a | Oct 3, 25 |
Dockery Carl Director | Acquired (grant/award) | +10K 0.09% of company | added 96% | 20K | n/a | Oct 3, 25 |
Jain Abhinav Director | Acquired (grant/award) | +10K 0.09% of company | added 100% | 20K | n/a | Oct 3, 25 |
Liu Vivian H Director | Acquired (grant/award) | +10K 0.09% of company | added 100% | 20K | n/a | Oct 3, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on AYTU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AYTU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AYTU last traded at $2.12, up 5.95% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
AYTU BioPharma, Inc. Common Stock (AYTU) is next expected to report earnings on Tuesday, September 22, 2026 (after close), about 2 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AYTU Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AYTU 0 times in the last 30 days.
AYTU (AYTU BioPharma, Inc. Common Stock) trades on XNAS, with a market cap of about $23M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AYTU for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AYTU discussion
Sign in to ask a question or join the discussion.